Baseline clinical characteristics
Initially, a total of 210 patients with locally advanced or metastatic HCC were included in this study according to the inclusion and exclusion criteria (Table S1). Compared to anlotinib group, patients in…
Efficacy and safety of anlotinib monotherapy for advanced hepatocellular carcinoma and clinical role of α-fetoprotein
